Relationship between CCR2-V64I polymorphism and cancer risk: A meta-analysis

Gene

Volumn 524, Issue 1, 2013, Pages 54-58

  Huang, Yuyun ^a   Chen, Huilong ^a   Wang, Jianmiao ^a   Bunjhoo, Hansvin ^a   Xiong, Weining ^a   Xu, Yongjian ^a   Zhao, Jianping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cancer risk; CCR2; Meta analysis; Polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR2;

ARTICLE; ASIAN; BLADDER CANCER; CANCER PATIENT; CANCER RISK; ETHNICITY; EUROPE; GENETIC POLYMORPHISM; HUMAN; MOUTH CANCER; PRIORITY JOURNAL; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER;

ASIAN CONTINENTAL ANCESTRY GROUP; CONFIDENCE INTERVALS; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOUTH NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RECEPTORS, CCR2; RISK FACTORS; URINARY BLADDER NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 84878106889     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.04.011     Document Type: Article

References (22)

1. Attar R., et al. Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women. In Vivo 2010, 24:243-248.
2. Bektas-Kayhan K., Unur M., Boy-Metin Z., Cakmakoglu B. MCP-1 and CCR2 gene variants in oral squamous cell carcinoma. Oral Dis. 2012, 18:55-59.
3. Bracci P.M., et al. Chemokine polymorphisms and lymphoma: a pooled analysis. Leuk. Lymphoma 2010, 51:497-506.
4. Charo I.F., Myers S.J., Herman A., Franci C., Connolly A.J., Coughlin S.R. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2752-2756.
5. Chatterjee K., Dandara C., Hoffman M., Williamson A.L. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women. BMC Cancer 2010, 10:278.
6. Chen M.K., Yeh K.T., Chiou H.L., Lin C.W., Chung T.T., Yang S.F. CCR2-64I2011. gene polymorphism increase susceptibility to oral cancer. Oral Oncol 2011, 47:577-582.
7. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
8. Koide N., Nishio A., Sato T., Sugiyama A., Miyagawa S. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am. J. Gastroenterol. 2004, 99:1667-1674.
9. Kucukgergin C., Isman F.K., Cakmakoglu B., Sanli O., Seckin S. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer. DNA Cell Biol. 2012, 31:1418-1424.
10. Liou J.M., et al. RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women. J. Gastroenterol. 2008, 43:115-123.
11. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
12. Nakayama E.E., Tanaka Y., Nagai Y., Iwamoto A., Shioda T. A CCR2-V64I polymorphism affects stability of CCR2A isoform. AIDS 2004, 18:729-738.
13. Narter K.F., Agachan B., Sozen S., Cincin Z.B., Isbir T. CCR2-64I is a risk factor for development of bladder cancer. Genet. Mol. Res. 2010, 9:685-692.
14. Polentarutti N., Allavena P., Bianchi G., Giardina G., Basile A., Sozzani S., et al. IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences. J. Immunol. 1997, 158:2689-2694.
15. Sanders S.K., Crean S.M., Boxer P.A., Kellner D., LaRosa G.J., Hunt S.W. Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell. J. Immunol. 2000, 165:4877-4883.
16. Singh V., Srivastava P., Srivastava N., Kapoor R., Mittal R.D. Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population. Mol. Biol. Rep. 2011, 39:9827-9834.
17. Smith M.W., et al. CCR2 chemokine receptor and AIDS progression. Nat. Med. 1997, 3:1052-1053.
18. Vazquez-Lavista L.G., Lima G., Gabilondo F., Llorente L. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Urology 2009, 74:414-418.
19. Yeh C.B., et al. Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma. J. Surg. Oncol. 2010, 102:264-270.
20. Zafiropoulos A., Crikas N., Passam A.M., Spandidos D.A. Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J. Med. Genet. 2004, 41:e59.
21. Zhang T., et al. Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma. Circ. J. 2003, 67:54-60.
22. Zheng B., et al. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients. Anticancer. Res. 2006, 26:3669-3674.